OpenURL Connection Search

Select item for more details and to access through your institution.

Engineering a soluble extracellular erythropoietin receptor (EPObp) in Pichia pastoris to eliminate microheterogeneity, and its complex with erythropoietin.
Published in:
Protein Engineering, 1999, v. 12, n. 6, p. 505, doi. 10.1093/protein/12.6.505
By:
- Zhan, Hangjun;
- Liu, Beishan;
- Reid, Scott W.;
- Aoki, Kenneth H.;
- Li, Cuiwei;
- Syed, Rashid S.;
- Karkaria, Cyrus;
- Koe, Gary;
- Sitney, Karen;
- Hayenga, Kirk;
- Mistry, Firoz;
- Savel, Laura;
- Dreyer, Mark;
- Katz, Bradley A.;
- Schreurs, Jolanda;
- Matthews, David J.;
- Cheetham, Janet C.;
- Egrie, Joan;
- Giebel, Lutz B.;
- Stroud, Robert M.
Publication type:
Article
Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity.
Published in:
Journal of Cellular Physiology, 1995, v. 163, n. 2, p. 418, doi. 10.1002/jcp.1041630222
By:
- Cook, Paul W.;
- Ashton, Nina M.;
- Karkaria, Cyrus E.;
- Siess, Don C.;
- Shipley, Gary D.
Publication type:
Article
Carboxyl-terminal truncation of leucine<sub>76</sub> converts heparin-binding EGF-like growth factor from a heparin-enhancible to a heparin-suppressible growth factor.
Published in:
Journal of Cellular Physiology, 1995, v. 163, n. 2, p. 407, doi. 10.1002/jcp.1041630221
By:
- Cook, Paul W.;
- Damm, Deborah;
- Garrick, Brett L.;
- Wood, Kathleen M.;
- Karkaria, Cyrus E.;
- Higashiyama, Shigeki;
- Klagsbrun, Michael;
- Abraham, Judith A.
Publication type:
Article

Found: 3

Engineering a soluble extracellular erythropoietin receptor (EPObp) in Pichia pastoris to eliminate microheterogeneity, and its complex with erythropoietin.

Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity.

Carboxyl-terminal truncation of leucine<sub>76</sub> converts heparin-binding EGF-like growth factor from a heparin-enhancible to a heparin-suppressible growth factor.